- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2217EUR$2,500USD£1,931GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1774EUR$2,000USD£1,545GBP
- Report
- December 2024
- 30 Pages
Global
From €2439EUR$2,750USD£2,125GBP
- Report
- December 2024
- 30 Pages
Global
From €2439EUR$2,750USD£2,125GBP
- Report
- April 2023
- 160 Pages
Global
From €4389EUR$4,949USD£3,823GBP
- Report
- February 2024
- 110 Pages
Global
From €4212EUR$4,750USD£3,670GBP
- Report
- April 2023
- 115 Pages
Global
From €4212EUR$4,750USD£3,670GBP
- Report
- April 2023
- 116 Pages
Global
From €3990EUR$4,500USD£3,477GBP
- Report
- October 2024
- 140 Pages
Global
From €2217EUR$2,500USD£1,931GBP
- Report
- January 2025
- 105 Pages
Global
From €3500EUR$4,228USD£3,156GBP
- Report
- February 2025
- 135 Pages
Global
From €15958EUR$17,995USD£13,903GBP
- Report
- December 2024
- 70 Pages
Global
From €3543EUR$3,995USD£3,086GBP
- Report
- October 2022
- 81 Pages
Global
From €3099EUR$3,495USD£2,700GBP
- Report
- August 2024
- 133 Pages
China
From €1596EUR$1,800USD£1,391GBP
- Report
- August 2024
- 101 Pages
China
From €1596EUR$1,800USD£1,391GBP
- Report
- January 2024
- 109 Pages
United States
€3104EUR$3,500USD£2,704GBP
- Report
- February 2018
- 680 Pages
Global
From €19509EUR$22,000USD£16,997GBP
- Report
- March 2022
- 101 Pages
Global
From €3500EUR$4,228USD£3,156GBP
- Report
- October 2024
- 90 Pages
Global
From €3500EUR$4,228USD£3,156GBP
- Report
- October 2023
- 101 Pages
Global
From €3500EUR$4,228USD£3,156GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more